NCT01348425

Zilver PTX Drug-Eluting Peripheral Stent Study

Evaluation of the Zilver PTX Drug-Eluting Peripheral Stent

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 45 (actual)
• Sponsor: Cook Group Incorporated · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This randomized, post-market clinical study is intended to evaluate the delivery and deployment of longer Zilver PTX stents (≥ 100 mm) compared to shorter Zilver PTX stents (≤80 mm) for treatment of lesions of the above-the-knee femoropopliteal artery.

Conditions

• Peripheral Arterial Disease

Interventions

Type	Name	Description
DEVICE	Longer Zilver PTX Stents	Treatment with at least one 100 mm or longer Zilver PTX stent
DEVICE	Shorter Zilver PTX Stents	Treatment with Zilver PTX stents 80 mm or shorter only

Timeline

• Start date: 2011-05-01
• Primary completion: 2011-10-01
• Completion: 2012-09-01
• First posted: 2011-05-05
• Last updated: 2016-02-02
• Results posted: 2014-04-16

Locations

4 sites across 2 countries: Germany, Switzerland